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Background: The Electronic Prescription Service Release 2 (EPS2) in England has been designed to provide
electronic transmission of digitally-signed prescriptions between primary care providers, with the intent on
removing the large amounts of paper currently exchanged. As part of a wider evaluation of the EPS service, we
wished to explore pharmacists’ experience with the new system and their perceptions of its benefits and any
associated problems.
Methods: We conducted semi-structured telephone interviews with community pharmacists using EPS2. We used a
purposive sampling technique to obtain views from pharmacists working in pharmacies with a range of sizes and
locations and to include both independent pharmacies and multiples. Interviews were transcribed verbatim and
coded using grounded theory to identify the main factors that have influenced deployment and implementation in
the eyes of respondents. QSR Nvivo was used as to aid in this process.
Results: It became apparent from the analysis that respondents perceived a wide range of advantages of EPS
including improved safety, stock control, time management and improved relationships between pharmacy and
General Practice staff. Respondents did not perceive a large difference in terms of work processes or development
of their professional role. A large number of problems had been experienced in relation to both the technology
itself and the way it was used by General Practices. It became apparent that work-around procedures had been
developed for dealing with these issues but that not all these problems were perceived as having been addressed
sufficiently at source. This sometimes had implications for the extent of EPS2 use and also limited some of the
potential advantages of the EPS2 system, such as reduced effort in the management of prescription
reimbursement. Respondents made suggestions for future improvements to EPS2. While interview data
demonstrated that there were some feedback procedures in place, these were not regarded as being sufficient by
the majority of respondents.
Conclusions: Whilst pharmacists perceived a wide range of benefits of EPS, a large number of problems had been
experienced. Despite these difficulties, no pharmacists expressed an overall negative view.Background
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The role of EPS is a fundamentally simple one: it allows
the transmission of prescription messages and digitally-
signed prescriptions via a central network and server infra-
structure, the Spine, from where they can be downloaded
by dispensing contractors including community phar-
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electronically to NHS Prescription Services for reimburse-
ment. There have been two releases of EPS (EPS1, EPS2).
EPS1, in use since 2005, prints a barcode on the prescrip-
tion form. This can be scanned by the pharmacy to initiate
a download of data, although the paper prescription still
remains the legal entity for dispensing and reimburse-
ment. In EPS2 a digital prescription is sent to the Spine,
which a pharmacy can then download and dispense. The
patient can nominate a specific pharmacy and the pre-
scription is directed there. Completion of dispensing by
the community pharmacy initiates a claim message to be
sent to NHS Prescription Services, the body responsible
for calculating reimbursements and remunerations, obvi-
ating the need for them to receive paper prescriptions.
The introduction of EPS2 has been associated with a
number of potential benefits for patients and staff. These
include the reduction of the number of illegible prescrip-
tions received, the promotion of increased use of repeat
dispensing prescriptions which should promote better
management of repeat prescriptions, and reduced effort
in the management of prescription reimbursement [1-3].
However, as Cornford, Doukidis and Forster eloquently
summarised, the outcomes from any workplace inter-
vention emerge from the fit between the technology in-
troduced and change to the work processes around the
use of the technology itself and not simply staff inter-
action with technology [4].
Although there are many tools that exist for the evalu-
ation of systems a priori, we cannot be certain as to how
these systems will operate in the real world. Related work
on the use of computerized physician order entry (elec-
tronic prescribing) and electronic transfer of prescriptions
in other countries shows that unintended consequences
can emerge from the introduction of electronic prescribing
related services [5-7]. Consequently, there is a need to ex-
plore how such systems operate in the real-world and how
errors in operation are mitigated and defended against.
Although the design of the EPS2 follows the traditional
paper process, there are a number of changes which might
lead to the adoption of new work practices. Firstly, the ser-
vice involves the introduction of a new intermediary in
the process of prescription transmission, the Spine. Prior
to EPS, the transfer of the paper prescription from the GP
practice to another responsible agency was transparent
and could be audited. In the case of EPS whilst the process
of transmission is potentially more reliable, there is an
intermediary system, which represents the boundary of
the GP practice’s responsibility but whose operation is not
visible to either GP practice or community pharmacy ex-
cept with regard to the delivery of the prescription. In-
deed, in the case of community pharmacy, transmission of
the prescription is not direct to the community pharmacy
but via a server acting as a community pharmacy messagehandler. The hand-over from the Spine to the message
handler is reported through a web portal, but the Spine
does not hold any data on what happens to the prescrip-
tion that the message handler does not send back. For ex-
ample, if a prescription got stuck in the message handler,
this would not be visible.
Secondly, the service does not cover all prescription
items; some fall outside of the scope of the service, in-
cluding controlled drugs and items that are not mapped
to the Dictionary of Medicines and Devices (DM + D).
In these cases, GP practice systems might offer the option
of splitting the prescription between paper and electronic
prescriptions, or simply require that the prescription is
printed on paper. There are management implications for
both of these scenarios. Where the prescription has been
split, the community pharmacy needs to be aware that the
patient’s prescription will be in two parts and that there is
a need to reconcile these. In those cases where the pre-
scription is provided on a paper document, the commu-
nity pharmacy needs to be aware that even in those cases
where the patient has a community pharmacy nomination
that a paper prescription needs to be obtained.
Finally, the location at which repeat dispensing pre-
scriptions are stored moves from the community phar-
macy to the Spine. Each issue of a repeat dispensing
prescription is issued according to a fixed schedule, which
is either set explicitly by the prescriber, or is set by the
Spine automatically. Each issue will be available to the
nominated community pharmacy a week before the medi-
cation is required. However, the Spine only knows when
the prescription is due if the community pharmacy puts a
notification on the system that it has been dispensed.
From feedback received, we understood that there might
be delays in this process.
Undoubtedly there are further subtle changes that emerge
from the operation of EPS which need to be taken into ac-
count, and which will require change in the manner com-
munity pharmacies manage prescriptions.
In this paper, we address five main research questions
related to pharmacy staff interaction with the new service.
First, how have work processes changed as a consequence
of the introduction of EPS2? Second, what advantages do
pharmacists perceive in the service and how have the goals
that community pharmacy expects to fulfill changed? Third,
what process disruptions emerge as a consequence of hu-
man or system error? Fourth, how do community pharma-
cies mitigate these process disruptions? Finally, what are
the feedback procedures available to community pharmacy
staff when they experience these disruptions?.
This paper follows on from some very early pilot work
with community pharmacies in which the authors re-
ported some preliminary findings but suggested further
studies to establish how the system operated when more
mature. We therefore conducted further interviews when
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into their experience.
Methods
This study aimed to provide data that would support the
interpretation of concurrent quantitative data focusing
on dispensing accuracy and dispensing interventions [8]).
It appeared most appropriate to conduct semi-structured
interviews with participants as we were seeking pharma-
cists’ viewpoints, which cannot be obtained by observa-
tion. This provided an opportunity to confirm established
knowledge about the service and also to explore the issues
that participants identified as particularly salient to the re-
search questions.
Ethical requirements
This was part of a larger project which had been classed
as a service evaluation and hence not requiring ethical
committee approval. This status was confirmed with the
chair of the Cambridgeshire I Research Ethics Committee.
Respondents were provided with an information sheet,
which reminded them that participation was voluntary
and of their right to withdraw at any time. Verbal con-
sent was gained from respondents at the start of the
interview. All data collected were anonymised in accord
with the standard practices adopted by this project.
Sampling
In this study our focus was on the community pharma-
cists who used EPS2 and who were responsible for the
reconfiguration of their workplaces to support activity.
Given the aim of the study to provide explanation of the
results obtained from the study of dispensing reliability,
the initial group of respondents was drawn from those
community pharmacies already studied. However, these
did not represent the only sites using EPS2 and conse-
quently, we also recruited additional sites to provide fur-
ther insight into the operation of EPS2 in community
pharmacy. Data obtained from the NHS Business Author-
ity showed that at the start of this research, in July 2012
there were 598 pharmacy contractors offering EPS2 ser-
vices in the UK. We sampled from these, using a max-
imum variation purposive sampling technique in order to
obtain views from pharmacists working in pharmacies
with a wide range of size, in a range of geographical loca-
tions to include pharmacists working in both independent
pharmacies and multiples and to include pharmacists with
varying levels of experience with EPS2.
Sample
This study was qualitative in nature. We had been fol-
lowing all the early adopter pharmacies since EPS2 went
live. Although there were over 500 pharmacies that were
offering the service at the time of our study, very fewhad a GP practice that was regularly sending prescrip-
tions by EPS2; in our estimation there were about 78
pharmacies in England that were using the service suffi-
ciently frequently to be able to comment on it with some
authority, and we drew our sample from these. We con-
ducted data analysis concurrently with the interviews and
as such continued interviewing until theoretical saturation
was reached. This occurred when 13 pharmacists had been
interviewed.
Recruitment
Researchers who were visiting the community pharma-
cies previously recruited to our wider study took letters
with them asking them to participate in this specific part
of the study. In addition, we asked one of the Primary
Care Trusts (PCTs) which had deployed EPS2 widely to
suggest some community pharmacies. These community
pharmacies were sent an email followed by a telephone
call. We asked pharmacists to either contact SG directly,
or to indicate to the researcher they were happy to par-
ticipate. All community pharmacies approached were in
PCTs that were proactive in promoting EPS2.
Data collection
Individuals agreeing to participate were contacted by
telephone to arrange a mutually convenient time to con-
duct the interview. The interviews were conducted by
telephone using a semi-structured interview schedule which
addressed the research objectives (see Additional file 1).
With verbal consent of the respondents, the interviews
were audio recorded.
Analysis
Interviews were transcribed verbatim and coded using
the four stages of grounded theory [9] to identify the main
factors that have influenced deployment and implementa-
tion in the eyes of respondents. QSR Nvivo 8 was used as
to aid in this process. Themes that were pertinent to the
research objectives were initially identified from a litera-
ture review and preliminary findings from pilot work. In-
terviews were then coded into these existing categories.
New categories and sub categories were also developed
throughout the process, allowing an index structure to be
built. For example, some problems and concerns identified
from the pilot work, such as problems with missing pre-
scriptions, were part of the initial coding frame. However,
other problems such as the large amount of printing were
identified during the study and new codes were therefore
created.
Results
Sixteen pharmacists were approached and thirteen agreed
to participate, giving a response rate of 81%. Of the thir-
teen interviewees, five worked in independent pharmacies,
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in a supermarket pharmacy. Nine of the pharmacies had
only a single pharmacist working at any one time and the
other four had two. The number of dispensers ranged
from one to ten per pharmacy, with the mean being three.
The themes identified comprised: motivation for mov-
ing to an EPS2 system, training, types of prescriptions
received via the EPS2 system, process change to support
EPS2, overall views of EPS2, perceived advantages EPS2,
perceived changes to professional role related to EPS2,
problems associated with EPS2, suggested improvements
to the EPS2 system, and feedback procedures available
to pharmacists. Each of these are next described.
Motivation for moving to an EPS2 system
The interview data demonstrated that respondents de-
cided to sign up for EPS2 for a range of reasons. These
included sanctioning by others: six of the thirteen re-
spondents reported that the PCT was a motivating force,
two that they had to gone live because the GP practice
near them had done so, and two that the decision had
been taken by their head office. Other reasons reported
for going live included wanting to be at the forefront
(four respondents), being of the opinion that it would be
good for business (two respondents) and the perception
that it would save time (one respondent).
‘The large surgery next door to us were very keen on
doing a trial, and they sort of semi volunteered us for
it’. [interview pharmacy 5].
‘We wanted to be at the forefront and influence the
way that the things are implemented locally’.
[interview pharmacy 12].
Training
The majority of interviewees reported having had some
training to help them implement EPS2. Nine of the thir-
teen respondents had received training from their soft-
ware provider, two from Connecting for Health and one
from the head office of their pharmacy chain. However,
one respondent stated that he had not received any
training. Five respondents were of the view that self
learning had played an important role in the implemen-
tation of EPS2.
‘I think that we found most of the stuff out ourselves
in the end’. [interview pharmacy 13].
Training was delivered in a variety of formats, some-
times in combination, including face to face (six respon-
dents), on line training (three respondents), videos (two
respondents) and the provision of written information
(four respondents).It became apparent from the analysis that whilst many
respondents were generally positive about the training
they had received, there was some room for improvement
in some cases. Seven respondents reported that the train-
ing had been useful and sufficient. However, two were of
the view that it had been quite brief and one was of the
opinion that learning more trouble-shooting during train-
ing would be helpful. One of the respondents discussed
the fact that although he had received good training, he
was one of the first sites to go live and that others might
not now receive training that was as comprehensive. The
timing of training was also discussed by several respon-
dents. Three respondents reported that the timing had
been good. However, two were of the view that the train-
ing had been given too early, as there had then been delays
going live, resulting in it being forgotten. Conversely, two
respondents were of the view that it had been given too
late, after they had already learnt how to use it themselves;
one of these two respondents said that this was because of
previous experience of the trainer that it had been given
too early at other sites. One respondent had been given
training both before and after going live and found that
supportive. Another also suggested that this would be a
helpful approach.
‘I think that a lot of people when it comes to training,
they are very negative about pointing out negatives. …
A lot of the problems that you have are annoying
things and they can be sorted out if you know how to
sort them out’. [interview pharmacy 8].
‘It was very good because basically it was logging on
to the website and over time basically looking at it,
and it was done before we went live as well, so we
were ready for it’. [interview pharmacy 10].
‘It was due to go live and then it didn’t and then by
the time it did it was a number of months and then of
course you had forgotten what you were told’.
[interview pharmacy 6].
‘In a way you need it before you start getting
prescriptions as you need training around
nominations and so forth, but I think that there will
definitely be a place for a follow up, even just a short
one - three or four weeks, having put on new
prescriptions’. [interview pharmacy 8].
Types of prescriptions received electronically
Eleven of the thirteen interviewees reported that they
had started receiving and dispensing EPS2 prescriptions;
they had received both acute and repeat prescriptions. The
other two pharmacies (pharmacies 10 and 11) were EPS2-
live but had not yet started receiving EPS2 prescriptions.
The majority of respondents (eight) also reported receiv-
ing electronic repeat dispensing prescriptions. Of these,
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and two had expanded their repeat dispensing service fol-
lowing the introduction of EPS2. In at least one area the
expansion of the service was a result of new incentives for
repeat dispensing from the PCT which coincided with the
introduction of EPS2.
‘The repeat dispensing has increased a lot, however, I
wouldn’t like you to think that it is because of this,
because we have heard that the GPs have been
recently incentivised to put patients on to repeat
dispensing’. [interview pharmacy 14].
Process change to support EPS2
The majority of respondents reported that there had
been no or minimal process changes following the intro-
duction of EPS2. However, one interviewee was of the
opinion that it had simplified the process. Six respon-
dents reported that new standard operating procedures
had been written either by themselves or their head of-
fice. However, two had not created new standard operat-
ing procedures.
‘We are still having the dispensers, or the pre-reg or the
technicians. We are still having to take the medicine off
the shelf, and still having to put the labels on
themselves, and if a green [paper] prescription comes in
or an electronic prescription, the process is essentially
the same’. [interview pharmacy 7].
Overall views of EPS2
Five respondents expressed an overall view of EPS2. Two
were positive and the other three were mixed.
‘Out of ten, I’d give it an eight if that makes sense. …
On the whole it has been a positive process’.
[interview pharmacy 7].
Perceived advantages of EPS2
A range of benefits were reported to have been experi-
enced by pharmacists using EPS2. Respondents were
asked about the effect of EPS2 on safety. Ten were of
the opinion that using the EPS2 system reduced errors,
two did not think it made any difference and one did
not express an opinion. Of those of the view that EPS2
improved safety, eight stated that labeling errors were
reduced as information did not have to be manually
transferred from the prescription. However, there was an
acknowledgment by some of these respondents that ac-
curate labeling still relied on the prescriber entering the
correct information on the prescription in the first place.
Three respondents also reported that reduced pressure
from a more even workflow would (one respondent) or
did (two respondents) help reduce errors.‘Very straightforward and very accurate and very little
chance of making dose errors, because it’s obviously
just a duplicate of what the doctor has put on his
machine, so if it is going to be an error of dose it
comes from him’. [interview pharmacy 15].
The majority of respondents (eight) reported that EPS2
helped even out workflow and seven respondents were of
the view that the service saved (six) or would save (one)
time overall by reducing time spent on collecting prescrip-
tions from the GP practice, labeling and/or processing end
of month claims. However, one respondent was of the
view that workflow had improved at the beginning but not
any longer.
‘I suppose its … more of a steady flow because we
might download 2 or 3 times a day and the surgery
will do the same their end. Whereas before we would
collect all the prescriptions once a day, so the repeat
prescriptions. Now we can go down in the morning
and if [we] have it quiet we can check if there are any
more to do’. [interview pharmacy 6].
‘When you get the prescriptions electronically, with
printing the labels, it has become…just work-wise it
has become a lot quicker. Because, for example if you
have an ordinary prescription you have to look for the
item and find out what it is, enter the dose manually,
but with this one it is done for you already [interview
pharmacy 9].
When asked how EPS2 affected relationships between
pharmacies and GP Practices, the majority of respon-
dents (seven) were positive. Respondents reported that
EPS2 encouraged communication and strengthened rela-
tionships due to shared problem solving. One respond-
ent reported that the pharmacy had already had a good
relationship with the clinical staff at the GP practice but
this had now expanded to administrative staff as well.
Another was of the view that EPS2 gave doctors a
greater appreciation of the role pharmacists play in
interpreting their prescriptions. Two others reported
that it was now quicker to receive amended prescrip-
tions where necessary and one that it reduced emer-
gency supplies at the doctors’ request as the doctor
could now send a valid prescription immediately. How-
ever, one respondent was of the opinion EPS2 had not
affected pharmacist-GP relationships.
‘Well because we are working together with it, it is
new to them and new to us, we kind of, you are on
the same side aren’t you. We’re all trying to get to the
same conclusion, but also it is, when we have a
problem, and we are ringing up and they are dealing
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[interview pharmacy 6].
‘I wouldn’t think that it has made em. much
difference if any. It hasn’t because we still are the
same as when we were dealing with paper really’.
[interview pharmacy 1].
Views were split as to whether or not EPS2 helped to
improve stock control and reduce medication owings.
Five respondents reported that owings were reduced as
the prescriptions came in earlier, giving the pharmacist
time to order in stock required before the patient ar-
rived. One respondent stated that he therefore needed to
keep less items in stock. However, three respondents
expressed the view that EPS2 had not reduced owings
because they already had a good stock control system
due to good patient–pharmacy communication when or-
dering repeats or because most owings were due to
manufacturers being out of stock; a factor which EPS2
was unable to reduce.
‘Therefore even if there is something missing you
have got a good chance that it will come in before the
patient comes in. Whereas with the green [paper]
prescription, the normal one it has to be done there
and then, as it is usually brought in by hand, and the
patient if there is anything missing you don’t have that
extra time to get that item.’ [interview pharmacy 15].
‘Most of them, the manufacturers are out of stock
now, which are pretty bad at the minute and I would
not say that there has been much impact that way.’
[interview pharmacy 14].
A number of other benefits were identified by a
smaller numbers of respondents. Benefits for pharma-
cists included taking a perceived step forward (two re-
spondents), retaining access to prescriptions rather than
needing to send the prescriptions off and therefore being
able to deal with queries on past prescriptions more effi-
ciently (one respondent), the potential that EPS2 would
lead to pharmacist access to clinical records in the future
(one respondent), the potential that administrative time
dealing with repeat dispensing would be lower (one re-
spondent) improved relationships with patients (one re-
spondent) and high street pharmacies (pharmacies on the
main shopping street) receiving more prescriptions (one
respondent). Perceived benefits for patients included less
waiting time in the pharmacy (two respondents), quicker
processing of repeat requests (one respondent) and a more
efficient repeat dispensing service (one respondent). Per-
ceived benefits for the GP practice reported by individual
pharmacists included saving time, saving paper and in-
creased signing flexibility as the prescription was not tieddown to one doctor or one location. A general benefit sug-
gested by two respondents was that there were less pre-
scriptions lost in the system. This is an important finding
to consider in the context of considering missing electronic
prescription as described in the problems and concerns
section below.
‘Whereas before if you handed a repeat form in, it
should have come to us, but we all know that
prescriptions go. So there is a lot less wayward
prescriptions’. [interview pharmacy 8].
Changes to professional roles associated with EPS2
The majority (nine) of respondents expressed the view
that EPS2 had not impacted on the professional role of
pharmacists and that they were still carrying out the
same roles as before. However, three respondents were
of the view that improved workflow and safety of EPS2
had freed up some of their time from dispensing to allow
them to carry out other professional roles. In addition,
two respondents expressed the opinion that EPS2 had im-
proved their professional relationship with patients and
one respondent saw the improved relationship with the
GP practice as an advancement of their professional role.
‘Professional, I don’t think that anything has changed,
because we are still dispensing or seeing the patients
and speaking to them, and so I don’t think that it has
changed or made any changes with the professional
role’. [interview pharmacy 9].
‘It frees up your time a lot more, and because, so as I
say because you can organise things a lot better, you
know when, you can choose when to check the
prescriptions and you know, there is less urgency
about it. … So you would be able to tie it in with
other things like MURs [medication use reviews] and
other services, and you know, that may be offered in
the pharmacist.’ [interview pharmacy 13].
Problems associated with EPS2
In parallel to the advantages of EPS2 discussed, respon-
dents described a range of problems which had occurred
during the use of EPS2. These included: system failures,
split prescriptions, missing prescriptions, codes not be-
ing recognized, problems with claiming, problems with
nominations, problems concerning smart cards, large
amount of printing, mixed ways of working, tensions
with GPs and tensions with patients.
System failures
Twelve of the thirteen respondents interviewed reported
experiencing problems when the system went down, al-
though interview pharmacy data demonstrated that this
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The remaining respondent had not yet received any EPS2
prescriptions. Two respondents expressed the view that
the problems had become less over time. It became appa-
rent from the analysis that there were many technological
components to the system and a problem occurring in
any of these components would create difficulty. These
components included the internet provider, the GP prac-
tice software, the Spine itself and the message provider
that transferred messages between the Spine and the phar-
macy. Interview data demonstrated that the way of dealing
with these difficulties was to ask the patient to come back
when the problem had been resolved or offer delivery.
Where more urgent acute prescriptions were needed or
the system was down for a prolonged period of time, the
pharmacy asked the GP practice to send the prescriptions
manually. However, one respondent said they had turned
EPS2 off completely and were in the process of changing
message provider, after which they would turn it on again.
‘When we first started out after about 4 or 5 months.
EPT2[EPS2], for some reason it has … the message
transmitter or whatever they called, failed to work for
3 days, and because it was a start up Connecting to
Health didn’t realise, now it took us 3 weeks nearly to
sort of out 3 days of problems. Trying to get things
reprinted, resorted and make sure that we had not
lost money or we had got everything out. We had the
same problem in June. EPT2 went down for 3 or 4
batches and it has taken somebody, a senior member
of staff, two and a half days to sort it out and we just
can’t be bothered any more’. [interview pharmacy 5].
‘Em. [It has gone down] a couple of times but it hasn’t
really given us any problems, so if it has gone down at
our end and not the doctors, we will just ring them
and say, “don’t send any more down until we let you
know” and if people are going for acute they’ll send
them out with a green [paper] one, and then if it goes
down the doctor then they just need a quiet spell and
in the worst case scenario they can fax prescriptions
across if it is desperate. But it hasn’t happened often’.
[interview pharmacy 6].Split prescriptions
Where prescriptions were split this was reported to be
due to controlled drugs or drug codes not being rec-
ognised electronically in the majority of cases. However,
one respondent stated that the split between electronic
and manual items could be quite random. Interview data
demonstrated that splitting of prescriptions caused prob-
lems, 1) because patients would arrive at the pharmacy
expecting all items to be there and no one would have
collected their paper prescriptions from the GP Practice(many English pharmacies operate prescription collec-
tion services for paper prescriptions), 2) because paper
items take longer to process so not all items would ar-
rive at the same time or 3) because the two sets of dis-
pensed items were not necessarily stored together at the
pharmacy. Strategies reported to have been developed to
deal with these situations included pharmacy staff put-
ting a note on the patient’s medication record to alert
the pharmacist that there were items on the record that
could not be sent electronically, checking the record
carefully, and educating patients that some items would
take longer to arrive than others. One respondent sug-
gested that it would be helpful to have an electronic
message, sent with the other items that the patient had
ordered, stating that there was also a controlled drug
which was being sent manually.
‘We have also done that for patients who receive any
controlled drugs on a monthly basis, so we have made
a note to say when you get release two prescriptions to
check if there are any control drug prescriptions waiting
in the surgery on paper’. [interview pharmacy 13].
‘Just I have been able to explain to patients that if they
have CDs [controlled drugs] on their prescriptions, it
takes, it might take longer’. [interview pharmacy 1].
Missing prescriptions
Five respondents reported some prescriptions had gone
missing, which was related to them being sent when there
were problems with the system being down in some cases.
However, interview data demonstrated that missing pre-
scriptions had not been a major problem in the majority of
cases. A method used by pharmacists to prevent missing
prescriptions was to not try downloading any prescriptions
when the system was down, but this could only work if the
pharmacist was aware the system was down. One respond-
ent reported that missing prescriptions became a more
major problem when prescriptions went missing and the
pharmacist did not know that there had been an attempt to
send them. The solution to missing prescriptions reported
by interviewees was to ask the GP practice to reissue pa-
tients with paper prescriptions.
‘I can only think of one time when it did occur and
that was because there had been an EMIS [general
practice computer system]update, and the
prescriptions had been done and been sent to the
Spine, but they had got stuck on the Spine and there
was no way of them coming down, but it affected very
few people cause EMIS were aware of the problem
and it got resolved within a day. The surgery reissued
the affected patients with paper prescriptions’.
[interview pharmacy 13].
Garfield et al. BMC Health Services Research 2013, 13:435 Page 8 of 14
http://www.biomedcentral.com/1472-6963/13/435‘We had a few lost prescriptions that we did not find
out about until 4 or 5 days afterwards. It is a massive
problem….Say if it is out for a couple of minutes and
you don’t know, and you just happen to try and
download scripts at that instant, it can actually block
it’. [interview pharmacy 8].
Five respondents also reported that prescriptions some-
times got delayed on the Spine, which could be a particu-
lar problem with acute prescriptions and where the GP
Practice and pharmacy were in close proximity. However,
this was not a problem experienced by all pharmacies.
‘What happens if they need medication, they have
seen the doctor, because the surgery is so close to us,
and the doctor says, ‘I have sent it to the pharmacy’
and then they [the patients] arrive here but the
prescription isn’t here. And depending on the
electronic traffic I get that goes through the system, if
it is too busy then it takes even longer to arrive’.
[interview pharmacy 2].
‘No, well even if we get acutes when they have been in
to see the doctor that morning, they are usually here
within about 5 minutes’. [interview pharmacy 13].Codes not being recognised
Problems reported with codes not being recognised applied
to both medication and dosing instructions. Some respon-
dents reported that these problems were reduced over time.
Others stated that they were resolvable if the GP Practice
or pharmacy staff knew what to do. Another reported that
he had to convert the code manually each time.
‘As time goes on the drugs are available’. [interview
pharmacy 7].
‘When ETP started, P my second pharmacist had to
go next door and put most of the stuff in a useable
form’. [interview pharmacy 5].
‘It processes it their end, but obviously whether it is in
the DM + D dictionary or not, it makes a difference,
so sometimes at this end we have to pick it up
manually and say, ‘these two are the same’ and try and
do it that way’. [interview pharmacy 12].Problems with claiming
Difficulties reported with claiming for dispensing included
the cumbersome nature of carrying out prescription en-
dorsements and concern that money was being lost on
some items. Two respondents stated that no accurate report
was automatically generated of how many items had been
submitted for payment so the pharmacist had to count
them manually to check they had been paid the correct
amount. Other cumbersome features reported were havingto change screens to endorse items (one respondent) and
having to go through everything line by line to check if any
extra endorsing was needed (one respondent). Other
reported problems were that a few items did not endorse
automatically ( two respondents) and that none of the items
on a prescription could be claimed for until any owings
were cleared (one respondent). One of the respondents
stated that the number of items not endorsed automatically
had reduced in time and that his software provider was able
to assist where necessary and the other said he had learned
how to resolve them. Difficulties were also described where
items were not in the drug tariff, were ‘specials’ or required
NCSO [no cheaper stock obtainable] endorsement because
items were not available at the usual price (five respon-
dents). Problems were reported to occur when claiming
for these items because any mistakes made could not later
be rectified and because the NCSO price had not always
been published at the time of dispensing. One respondent
described dealing with this problem by asking the GP
Practice to issue items requiring ‘special’ endorsing on
paper prescriptions. Whilst the majority of respondents
reported difficulties with claiming, two respondents expli-
citly stated that they had not experienced any problems,
although one of these respondents was not the owner and
did not directly deal with the financial side of the business.
‘I mean, good very accurate, I mean, except for
specials; I don’t think that it lends itself to items that
are not in the drug tariff ’. [interview pharmacy 15].
‘It is very straightforward and all the information that
you need to record is on each section and so for one
of the specials, you can go into that and it brings up
all the information up that you need to include’.
[interview pharmacy 13].Problems with nominations
Respondents reported a range of problems with nomina-
tions and different issues were raised by different respon-
dents. These included: patients being nominated to a
different pharmacy without their consent (three respon-
dents experienced and one respondent concerned), GPs
nominating the wrong pharmacy (two respondents), GPs
telling the patient to collect their prescription from the
closest pharmacy without checking that that was the one
they were nominated for (two respondents), the system not
allowing a particular patient to be nominated (one re-
spondent), patients being denominated from electronic
prescribing without their knowledge (one respondent), and
nomination not being changed back after having been
changed to allow access to out of hours services (one re-
spondent). One respondent stated that the problem with
GPs nominating the wrong pharmacy occurred because
s/he had selected the wrong branch of a chain. Interview
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were resolved by pharmacists changing the nomination
back to the correct one and patient education.
However, problems with nominations were not experi-
enced by all interviewees. Two respondents reported that
patients came to the wrong pharmacy but that the prob-
lem had not increased since EPS2 implementation as the
same thing could happen with paper prescriptions when
pharmacies offered prescription collection services and
patients did not remember which pharmacy they had
asked to pick up their prescription. A further two respon-
dents had experienced no problems with nominations.
‘We have found that quite often that doctors have
nominated the wrong pharmacy when they have had
the patients sat in front of them. And the other thing
is sometimes the GP, and we will have had this a few
times, where they have sent the patient over the road
to pick up the prescription from us, not realising that
the patient has been nominated at a different
pharmacy. And so we have been going ‘sorry it has
taken a little while to come, its taking a little while to
come’. We said, ‘has the doctor just nominated?’ ‘No I
use [name of pharmacy] and you say, ‘sorry that is
where you will get your prescription’. ‘The doctor said
‘go straight over the road’”. That is obviously not the
system’s fault, it is a training issue with the GP’.
[interview pharmacy 14].
We had some trouble; patients were nominated
allegedly by a different pharmacy without their
consent. There was a problem that without their
consent that someone else nominated them while
they were expecting the prescription to come here on
paper. It went to a different pharmacy electronically
[interview pharmacy 9].
‘That is not the fault of the EPS2. The same thing
happens with a lot of them with their paper
prescriptions. It tends to be the ones that tend to go
between pharmacies that have the problems
[interview pharmacy 8]’.Problems concerning smart cards
Some issues were reported with smart card use [cards to
permit user log in] but it came apparent from the inter-
view data that these had not caused major problems. Two
respondents reported that there had been some issues with
smart cards not working. The smart card system was set
up so that each individual would use their own smart card.
However, two respondents identified that there was some
flexibility with smart card use. There were mixed reports
about smart card availability for locums, with two respon-
dents stating that their locums did have smart cards and
three stating that they were not available. However, thiswas not considered to cause major difficulty as smart cards
were only needed to download and send off prescriptions,
and they could be downloaded by a dispenser. One re-
spondent reported experiencing a problem with an expired
smart card at the GP Practice end which meant that the
prescription could not be downloaded by the pharmacist.
‘We only have two in the dispensary and people have
left and they have not been replaced, and one of them
is out of date and doesn’t work. I mean, what tends to
happen is that one smart card gets put in and
everyone uses the smart card. …So it doesn’t actually
kind of lend itself to everyone doing their own work
on their own smart card’. [interview pharmacy 15].
‘Actually you don’t need a smart card all the time.
Once you have it downloaded you can do quite a lot
without a smart card even in’. [interview pharmacy 6].Large amount of printing
Five respondents raised the issue of the large amount of
printing which the pharmacist has to do with EPS2. Re-
spondents expressed the view that whilst in theory, EPS2
was meant to be a paperless system, this was not borne out
in practice and the printing had instead been transferred
from the GP Practice to the pharmacy. Printing of tokens
was reported to be necessary because pharmacists needed
something to dispense and check against and could not
keep the computer screen showing one prescription while
these processes took place. In addition, respondents
reported having to print out exemption declaration forms
for patients and repeat forms. One respondent complained
that the repeat forms automatically printed out in duplicate
where there were more than four items on the prescription
creating even more paperwork. Respondents expressed the
view that this caused expense to the pharmacists which
were not met by the allowance given for using EPS2.
‘I’m paying for the tokens, the NHS … isn’t. The NHS
isn’t paying for the green forms, because they are not
going to be using them. They are going to be emailing,
so there is not going to be a paper … I’ve got to pay for
printing out. I’ve got to … pay for the toner and I have
to pay for the paper. I think that somebody somewhere
has thought that is a good jape. We will get the
pharmacists to pay for it’. [interview pharmacy 11].
‘If you think about the demography of prescriptions,
most of them are people with exemptions and most of
those people will order their own medication, so they
need a reorder slip. You have to print off a token, and
if you are any way busy you can’t be running around
checking screens. You have to have something paper
to check. If you have got to do MURs and this that
and the other, you really have to. Sometimes, when
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checked. You can’t keep a screen on hold, while
someone finds the time to come and check it’.
[interview pharmacy 5].
Mixed ways of working
Two respondents were of the view that it would be eas-
ier if they received all prescriptions electronically rather
than some electronically and some manually. In one
case, the GP Practice sometimes sent them electronically
and sometimes manually and in the other case, one of
the two GP Practices attached to the pharmacy had gone
live and the other hadn’t.
‘Well, like when all our surgeries go to the same
system, it will just make it easier for us to be working
on. Any one system is easier to deal with rather than
a number of systems’. [interview pharmacy 6].
Whilst the majority of respondents expressed the view
that EPS2 reduced error, two respondents expressed
concerns relating to safety and security. One respondent
was of the view that manually endorsing prescriptions
could act as an extra checking stage and that automatic
endorsing took that away. The second expressed the
opinion that electronic transfer of prescriptions may be
insecure as patient’s records could get hacked into or an
individual could fraudulently claim to be a particular
patient in order to obtain their medication.
‘People’s telephones can get hacked into … and
probably it can with somebody determined. I don’t
know if anybody has tried it.… The other thing is of
course okay the doctor is not going … to be issuing
paper to the patient. How do you necessarily know for
example if it isn’t a regular patient, and they have
said, ‘I want my prescription at so and so pharmacy, I
passed it on my way into the surgery, I want it sent
there’. They know nothing about the patient. Are they
going to be given, some sort of paper collection data,
something in their hand to say that they are going to
be collected a prescription with a code number or
something on it. I am not sure about that’. [potential
problem interview pharmacy 11].
Difficulties with supplementary prescribing
Two respondents discussed a problem they had experi-
enced accessing prescriptions written by nurse pre-
scribers. This was reported to be due to the fact the
nurse had selected the GP rather than nurse prescription
form. One of the respondents started that this problem
was exacerbated because the system allowed the pre-
scription concerned to be sent at the GP Practice end
but that this could not then be downloaded at thepharmacy end. A suggestion was made that nurse pre-
scribers should be alerted by the software at their end
that the prescription was being blocked so that the prob-
lem could be resolved speedily at source.
Time consuming
Two respondents expressed the view EPS2 was time
consuming for the pharmacy because of claiming
(see above) and getting patient consent for nominations.
‘It saves the surgery time; the government save time
and the pricing bureau, the only people who have
more time to work on it are pharmacists’. [interview
pharmacy 5].
Tensions with GP Practices
It became apparent from the analysis that whilst EPS2 pro-
vided opportunities to work closely with GP Practices, it
also created some tension. Six respondents reported experi-
encing some difficulties although in the majority of cases re-
spondents were of the view that this had not caused a large
decline in overall relationships. Interview data demonstrated
that tensions occurred where the EPS2 process had failed or
where there were general failures in communication.
Interview data demonstrated that there had been some
difficulties in initialising EPS2 at the GP Practices. Four
respondents reported that they had had problems with
GPs not sending prescriptions electronically. Two of the
respondents stated that they had not yet received any
EPS2 prescriptions, one that they had received them
from some but not all GP Practices and one that they
had received few to begin with but that had now been
resolved. A fifth respondent expressed the view that
there was an enormous amount of work involved for GP
Practices in setting up EPS2.
‘Initially we did have a problem, but now it is not a
problem, they have all realised that for it to work, we
need to work together. …. I would have thought that
it should have improved it over all, but obviously with
certain individuals it can get fraught because they
don’t see the error of their way because, historically
GPs are just used to saying to pharmacists, ‘we are
right and you are wrong’. ‘[interview pharmacy 12].
‘We know that they are live, they are going live, the
PCT has told that they are live, but we are just having
some problems getting them to send us prescriptions
electronically [interview pharmacy 10].
‘I thought yeah, we will switch it over; there will be a
few problems. I was surprised how much more they’ve
had to alter. It has been a fairly mammoth thing … at
the GP’s end’ [interview pharmacy 8].
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Five respondents described tensions that could occur be-
tween the pharmacy and patient as a result of EPS2. It
became apparent from the analysis that these tensions
were caused either by patients becoming annoyed when
the system did not work as it should or by patients hav-
ing unrealistic expectations of what the system could do
even when functioning correctly. Respondents reported
that not all patients realised that they still had to actually
order their prescriptions each month. Another cause of
patient irritation reported was the expectation that the
prescription would be ready for patients when they get
to the pharmacy. In reality the prescription may take a
few minutes to arrive (as above) and then has to go into
the dispensing queue with paper prescriptions which
other patients have brought in. Interview data demon-
strated that in the majority of cases, these tensions could
be resolved by educating patients and GP Practices so
that patients’ expectations were more realistic. However,
in one pharmacy, patient irritation was reported to have
been one of the factors leading to the discontinuation of
EPS2. Another respondent was concerned that problems
with the system at these early stages made it more diffi-
cult to “sell” the service to patients.
‘We try to explain to them that the only thing that is
going to change is that it is going to come electronically
and always to the same pharmacy, rather than getting
lost in the system or kind of like just sitting on the
bench in the surgery’. [interview pharmacy 2].
‘Plus the irate patients is one of the main reasons as
well to switch it off. We are tired of being called
“idiots”. It is not our fault’. [interview pharmacy 5].Other problems
There were a range of problems only raised by individual
respondents. Some of these were anticipated problems
from a pharmacist who had not yet received any EPS2 pre-
scriptions and included: concern that she would no longer
be able to obtain seven day prescriptions for patients using
monitored dosing systems, apprehension that if the
pharmacist had a query with a downloaded prescription it
may be more difficult to leave it half done on the screen
while it was resolved, and concern that problems would
occur with the management of centralised dispensing i.e.
where the branch in which prescriptions were dispensed
was not the same as that from which prescriptions were
collected. Problems raised by an interviewee who was on
the implementation board for EPS2 as well as being a prac-
ticing pharmacist included the repeat forms printed off by
the pharmacist being in seemingly random rather than al-
phabetical order and messages to patients (for example, flu
vaccination due) coming together with repeat forms so thatthey may be less likely to be noticed by pharmacists and
passed on to patients than if they were separate. A third re-
spondent raised the issue of repeats coming too early, but
was of the view that this had been more or less resolved.
The same respondent also discussed the fact that when
there were breakdowns with the EPS2 system for prolonged
periods this could worsen workflow rather than improve it
because there may be one day where no prescriptions can
be dispensed and then the next double the amount would
need to be done. A fourth respondent reported that she
had experienced some difficulties when patients wanted
their repeat dispensing prescriptions early if, for example,
they were going on holiday. She discussed finding a solu-
tion to this by printing out the token and scanning it back
in, which then allowed the repeat to come through earlier.
Finally, a fifth respondent described the difficulties the GP
Practice had experienced in getting their staff trained as
they did not have funding to pay their staff to stay out of
surgery hours for training, and during surgeries the training
was constantly being interrupted.
Further suggested improvements
The majority of interviewees had some further suggestions
of how EPS2 could be improved. After discussing problems
and concerns, interviewees were asked if they had any fur-
ther suggested improvements for EPS2. Nine of the eleven
respondents had suggestions and these varied between re-
spondents. Some of the suggestions related to GP Practices,
others to the technology and one to patient education.
Suggestions relating to GP Practices
Two respondents suggested that further training for the
GPs on EPS2 would be helpful and another was of the
view that it would be helpful if pharmacists were able to
send messages to GPs; at present the system only allowed
one way communication between the GP Practice and the
pharmacy. Another respondent reported that increased
pressure from the PCT for General Practices to use EPS2
could be helpful. Yet another was of the view it would be
helpful for the pharmacy to be involved when the software
for EPS2 was being installed at the GP Practice so that
there was a shared understanding of what was involved.
“Something you can include in your thing is that
when they implement systems in GP Practices, they
should look to invite their local pharmacist there as
part of the training” [interview pharmacy 12].
Suggestions relating to technology
Other interviewees raised suggestions concerning the tech-
nology itself. These included: 1) developing a portable
device for EPS2 that the pharmacist could use when
checking the prescription rather than having to print the
prescriptions, 2) improvements in the software automatically
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tient, 3) having an automatic message come up on the Pa-
tient Medication Record to indicate whether the prescription
had been sent electronically or manually (making it easier to
trace when patients came in) and 4) allowing repeat dispens-
ing prescriptions to be downloaded earlier if necessary. Fi-
nally, one respondent was of the view that there should be
an electronic means for sending feedback messages to the
various parties involved with EPS2.
‘But also if they could bring in a mobile device so you
have a screen to check against, then there will be a
huge benefit paper wise’ [interview pharmacy 6].
‘Connecting for Health should have insisted on
something so that the system suppliers when they
created the software that they would have had that
inbuilt into it that this is a system we use for
communicating with us, or with the Connecting for
Health with the PCT, or you know because if you
have got a nice all singing and all dancing system, why
not use it to send messages’. [interview pharmacy 12].
Suggestion relating to patients
Another suggested improvement was education of patients
that this was a change for the NHS as a whole, rather than
individual pharmacies trying to get more prescriptions.
Feedback procedures and assistance with problems
A majority of respondents (eight) reported that assist-
ance was available when problems arose with EPS2, but
a majority (eight - but not the identical eight) expressed a
level of dissatisfaction with the support available. Sources of
assistance reported included the software provider, Con-
necting for Health and the PCT. A range of problems were
described with the support available including it taking too
long to be put through to the correct people to help, feed-
back not getting through to the right people, office people
not understanding community pharmacy in practice, prob-
lems taking too long to be resolved and not being informed
when a problem had been resolved. One respondent de-
scribed the frustration he experienced when trying to get
assistance and it became apparent that this was due to the
system comprising many components and no one taking
overall responsibility. Some respondents who had been part
of the initial pilot scheme described changes to feedback
procedures over the course of time. Two respondents were
of the view that as more sites had gone live, less support
was available as there were more people needing support
and software companies were less interested in feedback
than at the initial stages. Conversely, another respondent
reported having experienced more frustration at the begin-
ning as fewer support staff knew about EPS2 and it had
taken time to get through to the right people. Onerespondent expressed the concern that changes to the NHS
would further reduce the level of support available. Finally,
one respondent reported that he had not tried to use any
feedback mechanisms and did not have contact details of
any particular person to contact if he experienced problems.
‘The time that it happened, as I said, I have been able
to get through to the help desk and the help desk has
been able to solve it for me’. [interview pharmacy 1].
‘But it is so cumbersome, you have to pick about 15
different options before you get right down to ‘can
you please call me’. [interview pharmacy 12].
‘But anyhow, I think that probably if he can get to the
right people then the feedback is taken seriously and
if they don’t it is probably just ignored’. [interview
pharmacy 14].
‘I think that the other issue that is going to happen is
when the PCTs disappear, I think that there is going to
be no support for anyone’. [interview pharmacy 12].
Discussion
It became apparent from our analysis that respondents
perceived a wide range of advantages of EPS2 including
improved safety, stock control, time management and
doctor-pharmacy relationships. However, these did not
match the potential advantages originally suggested by
the Department of Health and NHS Connecting for Health
[1-3] which included reduction of illegible prescriptions,
promotion of repeat dispensing and reduced effort in pre-
scription reimbursement. Although pharmacists reported
an increase in repeat dispensing, only one expressed the
view that this was one of the benefits of EPS2. In addition,
respondents did not perceive a large difference in terms of
work processes or development of their professional role. A
sample of Canadian pharmacists interviewed by Motulsky
et al. [10] identified more perceived change in terms of their
professional role. However, in the Canadian system being
evaluated, clinical information was given to patients; in the
UK at present pharmacists do not receive any additional in-
formation over that received using the paper based system.
A large number of problems had been experienced in
relation to both the technology itself and the way it was
used by General Practices. Difficulties reported by the
majority of respondents included the system going down,
problems resulting from prescriptions being split with some
items coming electronically and some manually, problems
with codes not being recognised, problems with claiming
reimbursement and problems with nominations. It became
apparent that work-around procedures had been developed
for dealing with these issues but that not all these problems
had been addressed sufficiently at source. This sometimes
had implications for the extent of EPS2 use and also limited
some of the potential advantages of the EPS2 service, such
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bursement. Respondents made suggestions for future im-
provements to EPS2.
While interview data demonstrated that there were some
feedback procedures in place, these were not regarded as
being sufficient by the majority of respondents. Difficulties
experienced included it taking too long to be put through
to the correct people to help, feedback not getting through
to the right people, office people not understanding com-
munity pharmacy in practice, problems taking too long to
be resolved and not being informed when a problem had
been resolved.
The findings support and build upon those found by very
early interview work including: improvements to workflow
with EPS2, problems with missing prescriptions and an
overall relatively positive attitude to EPS2 despite problems
experienced. However this study has identified many other
issues that have arisen as the system has matured further.
It has also clarified that whilst workflow was improved
overall, system failures could lead to a less even workflow
at times. Our findings also build on exploratory work iden-
tifying interventions made by pharmacists when dispensing
EPS2 prescriptions [8]. Problems which needed to be re-
solved included split prescriptions between paper and elec-
tronic, missing prescriptions and use of Latin abbreviations
on directions which needed to be changed by the pharma-
cist. These problems, amongst many others, were all re-
ported by the pharmacists in the present study.
Many of our findings are also supported by previous
surveys of community pharmacy staff attitudes towards
electronic prescriptions in America and Sweden [11,12].
Positive features identified in both our study and at least
one of the other studies [11,12] included improved speed/
efficiency, reduced interruptions, increased prescription
integrity/security and improved relationships with pre-
scribers. Negative features were prescribing errors, delays
in receiving the electronic prescription, technical problems,
reduced communication with prescriber or patient, elec-
tronic prescriptions being lost or sent to the wrong phar-
macy, no alert in computer that an electronic prescription
has been received, decreased prescription integrity/
security, that prescribers used different medication codes to
pharmacists and that electronic prescriptions could not be
used for controlled drugs.
However, there were some differences in the findings
between our study and others. Legibility of prescriptions
was a benefit identified from the American and Swedish
surveys of electronic prescriptions but not from our ana-
lysis of the English EPS2 service. Also, Rupp et al. [11]
identified missing or insufficient information on the elec-
tronic prescription as a problem; this was not identified in
our study. These differences were probably due to elec-
tronic prescribing already being widely implemented in
England prior to the introduction of electronic transfer. Inaddition, 28% of the respondents in Sweden stated that it
was more inconvenient to make changes or corrections
with electronic prescriptions, a problem we did not iden-
tify in our English study. The difference was probably
related to differences in the particular systems used in
Sweden versus England. Novel issues identified by a large
number of respondents in our study that had not been
identified in previous work included improved stock
control, problems with split prescriptions and problems
with claiming reimbursement.
Limitations
This was an exploratory study of the experiences of phar-
macists in England who were early adoptors of EPS2. The
sample was fairly small and taken from PCTs who were
proactive in promoting EPS2 which had the potential to
introduce bias. However, we were able to obtain views
from a wide range of pharmacists including those working
in different types and sizes of pharmacy, in diverse loca-
tions and with a varying range of experience of EPS2.
Pharmacists who had very negative views of the system
may have been less likely to participate. On the other
hand, expressing these views and trying to evoke change
may have also been a reason for participation. A number
of pharmacists did express a great deal of frustration with
aspects of EPS2 during interviews and this had not de-
terred them from participating in the interviews.
Conclusions
Pharmacists reported little process change as a result
of the introduction of EPS2. Respondents described
a large number of problems that had occurred and
the majority of respondents did not find feedback proce-
dures satisfactory in terms of resolving problems and
improving the service. However, beyond all these
difficulties respondents could see many advantages of the
EPS2 system and perceived it as the way forward. Even the
respondents who reported experiencing a great deal of
frustration did not express an overall negative view.
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